Independent publication uses peripheral blood mononuclear cells (PBMCs) supplied by HemaCare to explore the effects of IgE sequestration in a humanized mouse model of immunoglobulin production
Recent data suggest that the average person has about a 40% chance of developing cancer at some point in his or her lifetime.  If those statistics are not frightening enough, let’s talk treatment: chemotherapy, radiation, surgery, chemical-based drug therapy, or a combination of the above. And don’t forget the various side effects of cancer therapy, many of which are a result of the destruction of crucial adult stem cells in the body. Because of this, stem cell transplants have been performed with fresh stem cells originating from bone marrow, peripheral blood, or cord blood to help replenish a patient’s hematopoietic system.